Sari, Murat <br/><br/>
Myelodysplastic Syndrome After Olaparib Treatment in Heavily Pretreated Ovarian Carcinoma.  [electronic resource] 

 -  American journal of therapeutics   
 - e632-e633 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1536-3686 
<br/><br/><label>Standard No.: </label>10.1097/MJT.0000000000000838  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>BRCA1 Protein--genetics<br/>Carcinoma, Ovarian Epithelial--genetics<br/>Chemotherapy, Adjuvant--adverse effects<br/>Female<br/>Germ-Line Mutation<br/>Humans<br/>Myelodysplastic Syndromes--blood<br/>Neoplasm Recurrence, Local--drug therapy<br/>Ovarian Neoplasms--genetics<br/>Ovariectomy<br/>Phthalazines--adverse effects<br/>Piperazines--adverse effects<br/>Poly(ADP-ribose) Polymerase Inhibitors--adverse effects